Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pelvic Neoplasms 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Mesothelioma 1Malignant Solid Neoplasm 1Lung Neoplasms 1Leiomyoma 1Colorectal Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1Chylous Ascites 1Carcinoma, Non-Small-Cell Lung 1Adenomyosis 1Abdominal Neoplasms 1

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Iohexol × Clear all
NCT01188486 2018-04-17

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

Stanford University

Phase NA Terminated
12 enrolled
Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mesothelioma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡